Search for: "JOHNSON v. JOHNSON" Results 5021 - 5040 of 9,975
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Aug 2011, 11:13 am
If a message conveyed by an ad is literally true or ambiguous, the plaintiff must prove actual deception or a tendency to deceive and it may do so with properly conducted consumer evidence (Johnson & Johnson-Merck Consumer Pharm., Co. v Rhone-Poulenc Rorer Pharm (1994)). [read post]
3 May 2007, 12:07 pm
The primary examples of enantiomer patents that we regard as vulnerable include Forest Labs' Lexapro, Bristol-Myers' Plavix, AstraZeneca's Nexium and Johnson & Johnson's Levaquin. [read post]
25 Jun 2011, 4:38 am by Russell Beck
Johnson, 209 S.W.3d 644 (Tex. 2006), which, in hindsight, seems to have presaged the court’s Marsh v. [read post]
29 Jul 2009, 6:45 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Tri-Cyclen Lo (Norgestimate, Ethinyl estradiol) – US: Johnson & Johnson, Teva settle patent infringement proceedings – the reverse of a reverse payment? [read post]
8 Nov 2006, 6:31 am
Johnson FL-16 Tim Mahoney (Foley open) FL-22 Ron Klein v. [read post]
1 Dec 2010, 7:04 am by Jeanne Long
The Court denied over a dissent leave to appeal in Horvath v Johnson et al., No. 139996-7. [read post]